BMJ Evidence-Based Medicine

BMJ Evidence-Based Medicine is a peer-reviewed journal on the tools, methods and concepts of evidence-based medicine, launched in 1995 and published from London by the BMJ Publishing Group, with a 2025 Journal Impact Factor of 10.8（BMJ Evidence-Based Medicine）是 1995 年创刊、由（BMJ Publishing Group）在伦敦出版的循证医学工具、方法与理念领域的同行评审期刊，2025 年影响因子为 10.8。

Scope

• The journal publishes original evidence-based research along with insights and opinions on what matters for health care该刊发表原创循证研究，以及与医疗卫生重要事项相关的见解和观点。
• It focuses on the tools, methods and concepts that are basic and central to teaching and practising evidence-based medicine其聚焦于循证医学教学与实践中基础且核心的工具、方法与理念。
• Relevant research from primary studies and evidence syntheses on topics in general medicine is published该刊刊载来自原始研究与证据综合的、围绕全科医学主题的相关研究。^[1]
• Important tools for teaching and implementing evidence-based medicine in clinical practice are disseminated其传播用于临床实践中教授与落实循证医学的重要工具。
• Perspective, debate, analysis and opinion on trusted evidence and on relevant topics in the field are provided该刊提供针对可信证据与本领域相关议题的评述、辩论、分析与观点。
• A wide range of article types is accepted, including original research, debate, analysis and opinion其接受的文章类型广泛，涵盖原创研究、辩论、分析与观点类文章。^[2]
• The journal runs article series on rapid reviews methods, shared decision making, network meta-analysis and open science该刊设有快速综述方法、共同决策、网状荟萃分析与开放科学等专题系列。

History

• The journal was launched in 1995 and carried the title Evidence-Based Medicine until 2017该刊于 1995 年创刊，在 2017 年之前一直沿用（Evidence-Based Medicine）这一刊名。
• It was first published jointly by the American College of Physicians and the BMJ Publishing Group and is now owned by BMJ该刊最初由美国内科医师学会与（BMJ Publishing Group）共同出版，现由（BMJ）所有。
• The journal appears six times a year and has moved to online-only publication to remove the energy, water and chemical use of print production该刊每年出版 6 期，并已转为纯在线出版，以消除印刷生产所消耗的能源、水与化学品。
• It is a Plan S compliant Transformative Journal and offers authors a hybrid open access option该刊是符合（Plan S）要求的转型期刊，并向作者提供混合开放获取选项。
• Juan VA Franco of Heinrich-Heine University Düsseldorf was appointed editor-in-chief, succeeding Carl Heneghan who had held the post since June 2017（Heinrich-Heine University Dusseldorf）的（Juan VA Franco）获任主编，接替自 2017 年 6 月起担任该职务的（Carl Heneghan）。
• Its 2025 acceptance rate was nine per cent, with a median of one day to first editorial decision without review and one hundred and five days with review其 2025 年录用率为 9%，不经外审的首次编辑决定中位时间为 1 天，经外审则为 105 天。

Editors

• The editor-in-chief is Juan VA Franco, a family physician and researcher at Heinrich-Heine University Düsseldorf现任主编为（Juan VA Franco），是（Heinrich-Heine University Dusseldorf）的家庭医生与研究者。
• He heads the Evidence Synthesis Unit at that university and is affiliated with Cochrane他主管该校的证据综合单元，并与（Cochrane）相关联。
• He also works as a clinical editor for the BMJ and sits on the governing board of Cochrane他还担任（BMJ）的临床编辑，并是（Cochrane）理事会成员。
• Associate editors include Kerry Dwan of the Liverpool School of Tropical Medicine, Fares Alahdab of the University of Missouri and Paula Riganti of the University of British Columbia副主编包括利物浦热带医学院的（Kerry Dwan）、密苏里大学的（Fares Alahdab）与不列颠哥伦比亚大学的（Paula Riganti）。
• They also include Yusentha Balakrishna of the South African Medical Research Council together with Nicolas Meza and Eva Madrid of the University of Valparaiso还包括南非医学研究理事会的（Yusentha Balakrishna）以及瓦尔帕莱索大学的（Nicolas Meza）与（Eva Madrid）。